12:00 AM
 | 
Jul 23, 2007
 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck

Earnings on deck
No fewer than 21 biotech and pharma companies will report 2Q07 earnings this week. Respiratory and central nervous system company Sepracor might turn heads with expected 270% EPS growth from 2Q06 due in part to a strong top line. Analysts expect 2Q07 revenues of $327.2 million versus $264.4 million reported for 2Q06. On...

Read the full 296 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >